# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-22-030869
Filing Date
2022-11-28
Accepted
2022-11-28 16:06:33
Documents
84
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | arwr-20220930.htm iXBRL | 10-K | 2242979
2 | EX-23.1 | arwr-20220930xex231.htm | EX-23.1 | 3084
3 | EX-31.1 | arwr-20220930xex311.htm | EX-31.1 | 8949
4 | EX-31.2 | arwr-20220930xex312.htm | EX-31.2 | 8950
5 | EX-32.1 | arwr-20220930xex321.htm | EX-32.1 | 4528
6 | EX-32.2 | arwr-20220930xex322.htm | EX-32.2 | 4534
12 |  | arwr-20220930_g1.jpg | GRAPHIC | 91143
13 |  | arwr-20220930_g2.jpg | GRAPHIC | 32978
14 |  | arwr-20220930_g3.jpg | GRAPHIC | 107316
15 |  | arwr-20220930_g4.jpg | GRAPHIC | 121895
16 |  | arwr-20220930_g5.jpg | GRAPHIC | 122649
| Complete submission text file | 0001628280-22-030869.txt |  | 9982142

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | arwr-20220930.xsd | EX-101.SCH | 57349
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | arwr-20220930_cal.xml | EX-101.CAL | 94853
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | arwr-20220930_def.xml | EX-101.DEF | 266974
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | arwr-20220930_lab.xml | EX-101.LAB | 704760
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | arwr-20220930_pre.xml | EX-101.PRE | 478825
78 | EXTRACTED XBRL INSTANCE DOCUMENT | arwr-20220930_htm.xml | XML | 1350687

Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-38042 | Film No.: 221425407
SIC: 2834 Pharmaceutical Preparations